BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17216021)

  • 1. [Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)].
    Frediani B; Rossini M; Adami S; Bianchi G; Di Munno O; Sinigaglia L; Antonelli M; Minisola G;
    Reumatismo; 2006; 58(4):314-8. PubMed ID: 17216021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients.
    Chen J; Liu W; Lin Q; Chen L; Yin J; Huang H
    Int J Rheum Dis; 2014 Jan; 17(1):66-70. PubMed ID: 24131858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metabolism and vitamin D status in patients with multiple sclerosis.
    Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D levels and bone mass in rheumatoid arthritis.
    Brance ML; Brun LR; Lioi S; Sánchez A; Abdala M; Oliveri B
    Rheumatol Int; 2015 Mar; 35(3):499-505. PubMed ID: 24980067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of Vitamin D Status and Bone Turnover Markers in Rheumatoid Arthritis Complicated by Osteoporosis.
    Tan LM; Long TT; Guan XL; Wu SF; Zheng W; Fu HY; Wang QH; Meng YM; Wu Y; Zeng TT; Tian YJ; Yu JL; Chen JJ; Li H; Cao LP
    Ann Clin Lab Sci; 2018 Mar; 48(2):197-204. PubMed ID: 29678847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis.
    Tomizawa T; Ito H; Murata K; Hashimoto M; Tanaka M; Murakami K; Nishitani K; Azukizawa M; Okahata A; Doi K; Saito M; Furu M; Hamaguchi M; Mimori T; Matsuda S
    Arthritis Res Ther; 2019 Jul; 21(1):174. PubMed ID: 31307521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density.
    Rossini M; Viapiana O; Adami S; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Orsolini G; Gatti D
    Clin Exp Rheumatol; 2015; 33(1):77-83. PubMed ID: 25438096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).
    Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Pasalic KS; Balcune I; Ferraz-Amaro I; Tlustochowicz M; Butrimiene I; Punceviciene E; Toroptsova N; Grazio S; Morovic-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Salaffi F; Cutolo M
    Autoimmun Rev; 2017 May; 16(5):548-554. PubMed ID: 28279841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
    Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
    Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
    Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between serum 25-hydroxyvitamin D concentrations and disease activity in rheumatoid arthritis?
    Baykal T; Senel K; Alp F; Erdal A; Ugur M
    Bratisl Lek Listy; 2012; 113(10):610-1. PubMed ID: 23094901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 25-hydroxyvitamin D and vitamin D-binding protein on bone mineral density and disease activity in Malaysian patients with rheumatoid arthritis.
    Wong TH; Gupta ED; Radhakrishnan AK; Gun SC; Chembalingam G; Yeap SS
    Int J Rheum Dis; 2018 May; 21(5):992-1000. PubMed ID: 28217867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone Mineral Density, 25-OH Vitamin D and Inflammation in Patients with Psoriasis.
    Solak B; Dikicier BS; Celik HD; Erdem T
    Photodermatol Photoimmunol Photomed; 2016 May; 32(3):153-60. PubMed ID: 26869073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prophylaxis and treatment of osteoporosis in patients with rheumatoid arthritis (ORA study)].
    Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Pollähne W; Zink A; Zeidler H; Häntzschel H; Raspe H
    Z Rheumatol; 2011 Nov; 70(9):793-8, 800-2. PubMed ID: 21956827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of bone mineral density and the occurrence of osteoporosis from 15 to 20 years of disease onset in patients with rheumatoid arthritis.
    Hämäläinen H; Kautiainen H; Kaarela K; Kotaniemi A
    Clin Exp Rheumatol; 2005; 23(2):193-8. PubMed ID: 15895889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism.
    Oelzner P; Lehmann G; Eidner T; Franke S; Müller A; Wolf G; Hein G
    Rheumatol Int; 2006 Aug; 26(10):908-15. PubMed ID: 16404562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].
    Böttcher J; Pfeil A; Lehmann G; Heinrich B; Malich A; Hansch A; Petrovitch A; Mentzel HJ; Hein G; Kaiser WA
    Z Rheumatol; 2004 Dec; 63(6):473-82. PubMed ID: 15605213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status.
    Mok J; Brown C; Moore AEB; Min SS; Hampson G
    Endocr Res; 2018 Aug; 43(3):195-202. PubMed ID: 29652557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.